The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis.
Berberian
B J
BJ
Department of Dermatology, Georgetown University Medical Center, Washington, DC, USA.
Breneman
D L
DL
Drake
L A
LA
Gratton
D
D
Raimir
S S
SS
Phillips
S
S
Sulica
V I
VI
Bernstein
J E
JE
D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000982:Antipruritics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004311:Double-Blind Method; D004316:Doxepin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D010146:Pain / Q000139:chemically induced; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012894:Sleep Stages / Q000187:drug effects; D016896:Treatment Outcome; D014221:Triamcinolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000982:Antipruritics; D004316:Doxepin; D014221:Triamcinolone; D006854:Hydrocortisone